Protocols for Kidney Cancer
| HIC 0708002992 Mario Sznol M.D. Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma (ECOG #2805) |
| HIC 0509000643 Wasif Saif M.D. A Phase I, Open-Label Study Evaluating the Pharamacokinetics of Components of S-1 in Patients with Varying Degrees of Renal Function |
| HIC 0905005127 Mario Sznol M.D. A Phase 1, Multicenter, Opened-label, Dose-escalation, Multidose Study of MDX-1203 in Subects with Advanced/Recurrent Clear Cell Renal Cell Carcinoma or Relapsed/Refractory B-Cell Non-Hodgkin's Lympohoma |